MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Astec Lifesciences - BSE: 533138, NSE: ASTEC
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Astec Lifesciences
Astec Lifesciences
BSE: 533138|NSE: ASTEC|ISIN: INE563J01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 22, 17:00
24.15
0.2 (0.84%)
VOLUME 1,992
LIVE
NSE
May 22, 17:00
23.70
-0.3 (-1.25%)
VOLUME 748
« Mar 10
Notes to Accounts Year End : Mar '11
1.  Retirement Benefits
 
 Provision for Gratuity is made and provided on actuarial valuation
 basis. Other retirement benefits are accounted as per company''s policy.
 
 2.  In the absence of information available with the company, the
 natureofsupplierswho are registered as Micro, Small or medium
 enterprises under the Micro, Small and Medium Enterprises Development
 Act 2006, as at 31st March 2011, have not been given.
 
 3.  Contingent liabilities not provided for in respect of:-
 
 i.  Bank Guarantees outstanding Rs. 58.82 lacs(Rs. 85.88 lacs).
 
 ii.  Letters of Credit with banks: Rs. 1412.17 lacs(Rs. 778.65 lacs).
 
 iii.Bills discounted but not realized:Rs.314.24lacs(Rs. 462.81 lacs)
 
 iv.  Estimated amount of contracts remaining to be executed on capital
 account and not provided for Rs. 320.89 Lacs. (Rs. 219.99 Lacs.).  
 
 v.  Sales Tax demand, against which company''s appeal is pending before 
 Commissioner of Sales Tax (Appeal) of Rs. 53.02 Lacs.
 
 4.  Balances appearing under the head Sundry Creditors, Loans and
 Advances are subject to confirmation.
 
 5.  In the opinion of the Management the current Assets, Loans and
 Advances are not less than the values stated if realized in the
 ordinary course of business. The provision for all known liabilities
 are adequate and are not in excess of the amount considered reasonably
 necessary.
 
 6.  Related Party Transaction
 
 As per Accounting Standard (AS-18) on related party disclosures issued
 by the ICAI, the disclosures of transaction with related party are as
 follows:
 
 Nature of relation Name of Related Parties
 
 Key Management personnel Mr. Ashok V. Hiremath — Managing Director
 
 Relative of key management personnel Mr. Suresh Hiremath
 
 Ms. Supriya Hiremath
 
 Ms. Chitra Hiremath
 
 Ashok V. Hiremath HUF Company/entity in which director has Opus
 Chemicals Pvt. Ltd.
 
 significant influence Behram Chemicals Pvt. Ltd.
 
 Astec CropCare Pvt. Ltd.
 
 India TL Domain Pvt. Ltd.
 
 CreenGuard Technologies Pvt. Ltd.
 
 7.  Production includes re-processing, production for unit interse,
 third party production (job Work).
 
 8.  Previous years figures have been regrouped and/or rearranged
 wherever necessary in order to Conform to current year''s presentation.
 All the figures have been rounded off to nearest rupee.
Source : Dion Global Solutions Limited
Quick Links for asteclifesciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.